Ion Biotechnology Mexico Corporate Brochure

Ion Biotechnology Mexico Corporate Brochure

Ion Biotechnology México S.A de C.V. is focused on introducing Ion Biotechnology Aqueous Ligands (IBAL) to Latino markets in Central and South America, with the goal of ensuring widespread access to innovative therapies. Our strategic approach involves developing a diverse pipeline of finished drug candidates that utilize metal ions and innovative administration methods for targeted and effective therapies. Collaboration with licensed partners is crucial for conducting comprehensive clinical trials and gaining insights into IBAL-based therapies. To enhance accessibility, we plan to sublicense distribution rights within our territories, contributing to improved healthcare across the region. Join us in transforming healthcare in Latino markets through the power of IBAL.

For more information, refer to the attached file.

    • Related Articles

    • Ion Gel ZCM-25® Expanded Provider User Manual for Healthcare Providers

      Surgical Site Infections (SSIs) are a significant concern in healthcare settings, accounting for a significant portion of healthcare-associated infections (HAIs) and resulting in increased costs, morbidity, and mortality. The use of topical ...

    • Corporate Brochures for IBM

      Ion Biotechnology México S.A. de C.V. is dedicated to bringing the benefits of Ion Biotechnology Aqueous Ligands (IBAL) to Latino markets. Our aim is to expand throughout Central and South American regions, ensuring widespread access to these ...

    • Corporate Brochure for IAG

      The Ionic Alliance Group “IAG” is leading the international research, development, and manufacturing of IBAL, a new form of biotechnology. The Ionic Alliance Community fosters a collaborative environment where information, ideas, and data relating to ...

    • Ion Gel ZCM-25® Publication Clinical 1

      To evaluate the tolerability of the product Ion Gel ZCM-25®, measured as the degree of irritability: edema and/or erythema, during 14 days of administration in healthy subjects. Methods: Twenty research subjects of both genders were recruited, and a ...

    • Efficacy of Ion Gel ZCM-25® in the Antiviral Treatment Against Dengue Virus

      Background: Dengue virus is a significant pathogen responsible for various infections, particularly in healthcare environments, and presents substantial treatment challenges. The necessity for effective antiviral agents against Dengue is critical. ...